{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:25Z","timestamp":1786975585901,"version":"build-2736575974"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,3,26]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Despite the widespread availability of antiretroviral therapy (ART), people with HIV still experience high mortality after hospital admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether a linkage case management intervention (named \u201cDaraja\u201d [\u201cbridge\u201d in Kiswahili]) that was designed to address barriers to HIV care engagement could improve posthospital outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Single-blind, individually randomized clinical trial to evaluate the effectiveness of the Daraja intervention. The study was conducted in 20 hospitals in Northwestern Tanzania. Five hundred people with HIV who were either not treated (ART-naive) or had discontinued ART and were hospitalized for any reason were enrolled between March 2019 and February 2022. Participants were randomly assigned 1:1 to receive either the Daraja intervention or enhanced standard care and were followed up for 12 months through March 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>The Daraja intervention group (n\u2009=\u2009250) received up to 5 sessions conducted by a social worker at the hospital, in the home, and in the HIV clinic over a 3-month period. The enhanced standard care group (n\u2009=\u2009250) received predischarge HIV counseling and assistance in scheduling an HIV clinic appointment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was all-cause mortality at 12 months after enrollment. Secondary outcomes related to HIV clinic attendance, ART use, and viral load suppression were extracted from HIV medical records. Antiretroviral therapy adherence was self-reported and pharmacy records confirmed perfect adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age was 37 (SD, 12) years, 76.8% were female, 35.0% had CD4 cell counts of less than 100\/\u03bcL, and 80.4% were ART-naive. Intervention fidelity and uptake were high. A total of 85 participants (17.0%) died (43 in the intervention group; 42 in the enhanced standard care group); mortality did not differ by trial group (17.2% with intervention vs 16.8% with standard care; hazard ratio [HR], 1.01; 95% CI, 0.66-1.55;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.96). The intervention, compared with enhanced standard care, reduced time to HIV clinic linkage (HR, 1.50; 95% CI, 1.24-1.82;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) and ART initiation (HR, 1.56; 95% CI, 1.28-1.89;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Intervention participants also achieved higher rates of HIV clinic retention (87.4% vs 76.3%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.005), ART adherence (81.1% vs 67.6%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.002), and HIV viral load suppression (78.6% vs 67.1%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01) at 12 months. The mean cost of the Daraja intervention was about US $22 per participant including startup costs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Among hospitalized people with HIV, a linkage case management intervention did not reduce 12-month mortality outcomes. These findings may help inform decisions about the potential role of linkage case management among hospitalized people with HIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT03858998\">NCT03858998<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2024.2177","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T13:30:33Z","timestamp":1709731833000},"page":"1025","source":"Crossref","is-referenced-by-count":17,"title":["Linkage Case Management and Posthospitalization Outcomes in People With HIV"],"prefix":"10.1001","volume":"331","author":[{"given":"Robert N.","family":"Peck","sequence":"first","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"},{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Medicine, Weill Bugando School of Medicine, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Issarow","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey A.","family":"Kisigo","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Kabakama","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elialilia","family":"Okello","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rutachunzibwa","sequence":"additional","affiliation":[{"name":"Ministry of Health, Community Development, Gender, Elderly, and Children, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Willkens","sequence":"additional","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick","family":"Deogratias","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadhan","family":"Hashim","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Grosskurth","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ayieko","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Hee","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Metsch","sequence":"additional","affiliation":[{"name":"Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"Kapiga","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"13","key":"joi240019r3","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1097\/QAD.0000000000003006","article-title":"Incidence of HIV-positive admission and inpatient mortality in Malawi (2012-2019).","volume":"35","author":"Burke","year":"2021","journal-title":"AIDS"},{"issue":"3","key":"joi240019r4","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/S2352-3018(21)00329-5","article-title":"Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis.","volume":"9","author":"Ford","year":"2022","journal-title":"Lancet HIV"},{"issue":"10","key":"joi240019r5","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3018(15)00137-X","article-title":"Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis.","volume":"2","author":"Ford","year":"2015","journal-title":"Lancet HIV"},{"issue":"7","key":"joi240019r7","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/S2352-3018(23)00109-1","article-title":"Ending AIDS deaths requires improvements in clinical care for people with advanced HIV disease who are seriously ill.","volume":"10","author":"Burke","year":"2023","journal-title":"Lancet HIV"},{"issue":"5","key":"joi240019r8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/QAI.000000000001107","article-title":"Linkage to primary care and survival after hospital discharge for HIV-infected adults in Tanzania: a prospective cohort study.","volume":"73","author":"Peck","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"joi240019r9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/01.aids.0000161772.51900.eb","article-title":"Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care.","volume":"19","author":"Gardner","year":"2005","journal-title":"AIDS"},{"issue":"5","key":"joi240019r10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/QAI.0b013e3181684c51","article-title":"Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II.","volume":"47","author":"Craw","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"joi240019r11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/cid\/ciw322","article-title":"A randomized trial to test a peer mentor intervention to improve outcomes in persons hospitalized with HIV infection.","volume":"63","author":"Giordano","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"joi240019r12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2016.8914","article-title":"Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial.","volume":"316","author":"Metsch","year":"2016","journal-title":"JAMA"},{"key":"joi240019r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106680","article-title":"A social worker intervention to reduce post-hospital mortality in HIV-infected adults in Tanzania (Daraja): study protocol for a randomized controlled trial.","volume":"113","author":"Kisigo","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"6","key":"joi240019r15","first-page":"1273","article-title":"The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people.","volume":"34","author":"Gelberg","year":"2000","journal-title":"Health Serv Res"},{"issue":"2","key":"joi240019r16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/09540120600966182","article-title":"Factors associated with use of HIV primary care among persons recently diagnosed with HIV: examination of variables from the behavioural model of health-care utilization.","volume":"19","author":"Anthony","year":"2007","journal-title":"AIDS Care"},{"key":"joi240019r17","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/QAI.0b013e3181605df1","article-title":"The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions.","volume":"47","author":"Wingood","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"joi240019r18","first-page":"594","article-title":"Alcohol abuse among patients with and without HIV infection attending public clinics in western Kenya.","volume":"81","author":"Shaffer","year":"2004","journal-title":"East Afr Med J"},{"issue":"7078","key":"joi240019r19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bmj.314.7078.420","article-title":"Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study.","volume":"314","author":"Piccinelli","year":"1997","journal-title":"BMJ"},{"key":"joi240019r20","doi-asserted-by":"publisher","DOI":"10.1017\/gmh.2018.31","article-title":"Depression screening in HIV-positive Tanzanian adults: comparing the PHQ-2, PHQ-9 and WHO-5 questionnaires.","volume":"5","author":"Nolan","year":"2018","journal-title":"Glob Ment Health (Camb)"},{"issue":"12","key":"joi240019r21","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.socscimed.2009.04.005","article-title":"A comparison of HIV\/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV\/AIDS.","volume":"68","author":"Genberg","year":"2009","journal-title":"Soc Sci Med"},{"issue":"11","key":"joi240019r22","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1080\/09540121.2015.1098765","article-title":"Perceived social support among HIV patients newly enrolled in care in rural Ethiopia.","volume":"27","author":"Lifson","year":"2015","journal-title":"AIDS Care"},{"issue":"11","key":"joi240019r23","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0895-4356(98)00109-7","article-title":"Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project.","volume":"51","author":"Gandek","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"joi240019r25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/jech.2008.081554","article-title":"Verbal autopsy can consistently measure AIDS mortality: a validation study in Tanzania and Zimbabwe.","volume":"64","author":"Lopmari","year":"2010","journal-title":"J Epidemiol Community Health (1978)"},{"issue":"3","key":"joi240019r26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10461-006-9078-6","article-title":"Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management.","volume":"10","author":"Simoni","year":"2006","journal-title":"AIDS Behav"},{"issue":"1","key":"joi240019r30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12889-016-2883-6","article-title":"Cost and cost-effectiveness analysis of a community mobilisation intervention to reduce intimate partner violence in Kampala, Uganda.","volume":"16","author":"Michaels-Igbokwe","year":"2016","journal-title":"BMC Public Health"},{"issue":"10","key":"joi240019r31","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1097\/01.olq.0000200606.98181.42","article-title":"From trial intervention to scale-up: costs of an adolescent sexual health program in Mwanza, Tanzania.","volume":"33","author":"Terris-Prestholt","year":"2006","journal-title":"Sex Transm Dis"},{"issue":"S1","key":"joi240019r32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/tmi.2010.15.issue-s1","article-title":"Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa.","volume":"15","author":"Rosen","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"1","key":"joi240019r33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1478-7547-9-18","article-title":"Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study.","volume":"9","author":"Marseille","year":"2011","journal-title":"Cost Eff Resour Alloc"},{"issue":"12","key":"joi240019r34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208429","article-title":"Hospitalization and post-discharge care in South Africa: a critical event in the continuum of care.","volume":"13","author":"Cichowitz","year":"2018","journal-title":"PLoS One"},{"issue":"10144","key":"joi240019r35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(18)31267-4","article-title":"Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.","volume":"392","author":"Gupta-Wright","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"joi240019r36","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1016\/S2352-3018(20)30172-7","article-title":"Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study.","volume":"7","author":"Gupta-Wright","year":"2020","journal-title":"Lancet HIV"},{"issue":"10","key":"joi240019r37","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/cid\/ciz1133","article-title":"Tuberculosis in hospitalized patients with human immunodeficiency virus: clinical characteristics, mortality, and implications from the rapid urine-based screening for tuberculosis to reduce AIDS related mortality in hospitalized patients in Africa.","volume":"71","author":"Gupta-Wright","year":"2020","journal-title":"CID"},{"key":"joi240019r27","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780190492939.001.0001","volume-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2016","edition":"2nd ed"},{"key":"joi240019r1","unstructured":"UNAIDS. The Path That Ends AIDS: UNAIDS Global AIDS Update. Published 2023. Accessed August 23, 2023. https:\/\/www.unaids.org\/en\/resources\/documents\/2023\/global-aids-update-2023"},{"key":"joi240019r2","unstructured":"UNAIDS. Global HIV & AIDS Statistics\u2014Fact Sheet. Published 2023. Accessed August 23, 2023. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf"},{"key":"joi240019r6","unstructured":"World Health Organization. Providing care to people with advanced HIV disease who are seriously ill. Published 2023. Accessed July 24, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240068650"},{"key":"joi240019r14","unstructured":"Tanzania National AIDS Control Program. National Guidelines for the Management of HIV and AIDS. Published 2019. https:\/\/nacp.go.tz\/download\/national-guidelines-for-the-management-of-hiv-and-aids-april-2019\/"},{"key":"joi240019r24","unstructured":"World Health Organization. Verbal autopsy standards: the 2022 WHO verbal autopsy instrument. Published 2023. Accessed October 22, 2023. https:\/\/cdn.who.int\/media\/docs\/default-source\/classification\/other-classifications\/autopsy\/2022-va-instrument\/verbal-autopsy-standards-2022-who-verbal-autopsy-instrument-v1.2-for-publication.pdf?sfvrsn=9a33010f_8&download=true"},{"key":"joi240019r28","unstructured":"World Bank. Tanzania Mainland Poverty Assessment. Published 2020. Accessed October 22, 2023. https:\/\/www.worldbank.org\/content\/dam\/Worldbank\/document\/Africa\/Tanzania\/Report\/tanzania-poverty-assessment-05.2015.pdf"},{"key":"joi240019r29","unstructured":"Ubwani? Z. Health insurance covers 15 percent of Tanzanians. The Citizen. Published February 5, 2023. Accessed February 23, 2024. https:\/\/www.thecitizen.co.tz\/tanzania\/news\/national\/health-insurance-covers-15-percent-of-tanzanians-4112040"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2816177\/jama_peck_2024_oi_240019_1710443214.76997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T11:36:25Z","timestamp":1711452985000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2816177"}},"subtitle":["The Daraja Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,3,26]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.2177","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}